• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NOX 3.85% 13.5¢

NOXOPHARM LIMITED

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel... Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
NOX 29/10/24 0 261
29/10/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  261 
NOX 25/10/24 1 657
25/10/24 Last post  19661966 Comments Created with Sketch.  1  Views Created with Sketch.  657 
NOX 17/10/24 8 3.4K
17/10/24 Last post  Bendunstan Comments Created with Sketch.  8  Views Created with Sketch.  3.4K 
NOX 14/10/24 0 321
14/10/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  321 
NOX 14/10/24 0 232
14/10/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  232 
NOX 11/10/24 0 311
11/10/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  311 
NOX 09/10/24 26 7.7K
09/10/24 Last post  19661966 Comments Created with Sketch.  26  Views Created with Sketch.  7.7K 
NOX 30/09/24 0 304
30/09/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  304 

See All Discussions arrow Created with Sketch.

Timeline

September 2024 Quarterly Activities report and Appendix 4C
29 Oct 08:10
 
2024 AGM Addendum to the Notice of Meeting and Proxy
25 Oct 08:21
 
Minor correction to funding announcement
14 Oct 08:30
 
AGM Letter of Access, Notice of Meeting and Proxy
14 Oct 08:24
 
Unlisted Options Upcoming Expiry
11 Oct 07:39
 
SOF-SKN manufacturer signed for HERACLES clinical trial
10 Oct 08:26
 
View More arrow Created with Sketch.
(20min delay)
Last
13.5¢
Change
0.005(3.85%)
Mkt cap ! $39.45M
Open High Low Value Volume
13.0¢ 13.5¢ 13.0¢ $11.71K 89.67K

Buyers (Bids)

No. Vol. Price($)
2 84758 13.0¢
 

Sellers (Offers)

Price($) Vol. No.
13.5¢ 33763 1
View Market Depth
Last trade - 16.10pm 01/11/2024 (20 minute delay) ?
Last
13.5¢
  Change
0.005 ( 3.85 %)
Open High Low Volume
13.0¢ 13.5¢ 13.0¢ 90221
Last updated 15.47pm 01/11/2024 ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.